#ASGCT21 is available on demand until August 13!
Access the Meeting Platform

Porton Biologics

Explore Gene and Cell Therapy CDMO services with us!

Porton Biologics Ltd. (Portonbio) was established in 2018. Located in Suzhou Industrial Park, and as a wholly owned subsidiary of Porton Pharma Solutions Ltd, PortonBio provides Gene and Cell Therapy CDMO service for innovators from the early stage, IND filling and even commercial production.

Based on the successful experience of Porton Pharma Solution Ltd, Portonbio will take the international team as the core, adhere to the service concept of “Customer First and Excellence Always”, and take full advantage of high-level technology and equipment to create high-end biological and CDMO platform. Portonbio pursues to become a reliable partner for global pharmaceuticals and biotech companies.

Brands: End-to-End Gene and Cell Therapy CDMO | In China for Global | Innovation | Integration | Impact If you have any inquiry, please contact us via BD.SZ@portonbio.com.